These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3925289)

  • 1. Effect of inhibitors of proteolysis and arachidonic acid metabolism on burn-induced protein breakdown.
    Odessey R
    Metabolism; 1985 Jul; 34(7):616-20. PubMed ID: 3925289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 and muscle proteolysis: effect of burn injury and cycloheximide.
    McKinley CJ; Turinsky J
    Am J Physiol; 1986 Feb; 250(2 Pt 2):R207-10. PubMed ID: 3080903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of lysosomal proteolysis in burn injury.
    pdessey R
    Metabolism; 1987 Jul; 36(7):670-6. PubMed ID: 3298935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burn-induced stimulation of lysosomal enzyme activity in skeletal muscle.
    Odessey R
    Metabolism; 1986 Aug; 35(8):750-7. PubMed ID: 3526087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of various blockers of arachidonic acid metabolism on release of beta-endorphin- and adrenocorticotropin-like immunoreactivity induced by phospholipase A2 from rat adenohypophysis in vitro.
    Knepel W; Meyen G
    Neuroendocrinology; 1986; 43(1):44-8. PubMed ID: 3012392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 does not regulate total or myofibrillar protein breakdown in incubated skeletal muscle from normal or septic rats.
    Hasselgren PO; Zamir O; James JH; Fischer JE
    Biochem J; 1990 Aug; 270(1):45-50. PubMed ID: 2118760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of protein degradation in muscle by prostaglandins, Ca2+, and leukocytic pyrogen (interleukin 1).
    Goldberg AL; Baracos V; Rodemann P; Waxman L; Dinarello C
    Fed Proc; 1984 Apr; 43(5):1301-6. PubMed ID: 6323220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.
    Libby P; Goldberg AL
    Science; 1978 Feb; 199(4328):534-6. PubMed ID: 622552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered protein kinetics in vivo after single-limb burn injury.
    Shangraw RE; Turinsky J
    Biochem J; 1984 Nov; 223(3):747-53. PubMed ID: 6508738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin and leucine on protein turnover in rat soleus muscle after burn injury.
    Odessey R; Parr B
    Metabolism; 1982 Jan; 31(1):82-7. PubMed ID: 7043163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thermal injury on glucocorticoid and androgen binding in skeletal muscles with different fiber populations.
    Jacobson HI; Turinsky J
    J Trauma; 1982 Oct; 22(10):845-52. PubMed ID: 7131603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model to study local effects of thermal trauma on muscle metabolism.
    Odessey R; Allen ER; Newman WP
    Circ Shock; 1983; 11(2):131-40. PubMed ID: 6640857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway.
    Fang CH; Tiao G; James H; Ogle C; Fischer JE; Hasselgren PO
    J Am Coll Surg; 1995 Feb; 180(2):161-70. PubMed ID: 7850049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome blockers inhibit protein breakdown in skeletal muscle after burn injury in rats.
    Fang CH; Wang JJ; Hobler S; Li BG; Fischer JE; Hasselgren PO
    Clin Sci (Lond); 1998 Aug; 95(2):225-33. PubMed ID: 9680506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibitors of arachidonic acid metabolism on intercellular adhesion of SV40-3T3 cells.
    Evans PM; Lanham DF
    Cell Biol Int Rep; 1986 Sep; 10(9):693-8. PubMed ID: 3019579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease.
    Rodemann HP; Waxman L; Goldberg AL
    J Biol Chem; 1982 Aug; 257(15):8716-23. PubMed ID: 6807980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.
    Baracos V; Rodemann HP; Dinarello CA; Goldberg AL
    N Engl J Med; 1983 Mar; 308(10):553-8. PubMed ID: 6402699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid metabolism and thyrotropin secretion in vitro.
    Canonico PL; Valdenegro CA; Judd AM; MacLeod RM
    Eur J Pharmacol; 1984 Feb; 98(1):45-52. PubMed ID: 6425068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of arachidonic acid metabolism: effects on rat striatal dopamine release and uptake.
    Cass WA; Larson G; Fitzpatrick FA; Zahniser NR
    J Pharmacol Exp Ther; 1991 Jun; 257(3):990-6. PubMed ID: 1828506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway.
    Vlaskovska M; Knepel W
    Neuroendocrinology; 1984 Oct; 39(4):334-42. PubMed ID: 6092988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.